Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy

被引：52

作者：

Brown, P

机构：

[1] Bethesda, MD 20814

来源：

VOX SANGUINIS | 2005年 / 89卷 / 02期

关键词：

blood screening tests; Creutzfeldt-Jakob disease; prion protein; prion; scrapie; transmissible spongiform encephalopathy;

D O I：

10.1111/j.1423-0410.2005.00683.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Surprising advances have been made in the areas of blood infectivity, infectivity removal and, especially, blood screening tests for transmissible spongiform encephalopathy (TSE) in the past few years. In fact, if anyone as recently as last year had suggested that a screening test for preclinical human infection might be available before the end of 2005, the statement would have been met with smiling disbelief. Nevertheless, it can be confidently predicted that the diagnostic misfolded 'prion' protein (PrPTSE) will soon be reliably detectable in blood during the symptomatic phase of disease, and it is highly probable that it will also be detectable in blood from at least a proportion of infected individuals during the preclinical phase of disease.

引用

收藏

页码：63 / 70

页数：8

相关论文

共 26 条

[1] Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR [J].

Barletta, JM ;

Edelman, DC ;

Highsmith, WE ;

Constantine, NT .

JOURNAL OF VIROLOGICAL METHODS, 2005, 127 (02) :154-164

[2] Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets [J].

Bieschke, J ;

Giese, A ;

Schulz-Schaeffer, W ;

Zerr, I ;

Poser, S ;

Eigen, M ;

Kretzschmar, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5468-5473

[3] Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease [J].

Brown, P ;

Cervenáková, L ;

Diringer, H .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (01) :5-13

[4] The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy [J].

Brown, P ;

Rohwer, RG ;

Dunstan, BC ;

MacAuley, C ;

Gajdusek, DC ;

Drohan, WN .

TRANSFUSION, 1998, 38 (09) :810-816

[5] Iatrogenic Creutzfeldt-Jakob disease at the millennium [J].

Brown, P ;

Preece, M ;

Brandel, JP ;

Sato, T ;

McShane, L ;

Zerr, I ;

Fletcher, A ;

Will, RG ;

Pocchiari, M ;

Cashman, NR ;

d'Aignaux, JH ;

Cervenáková, L ;

Fradkin, J ;

Schonberger, LB ;

Collins, SJ .

NEUROLOGY, 2000, 55 (08) :1075-1081

[6]

Brown P, 1995, Curr Opin Hematol, V2, P472

[7] Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease [J].

Cervenakova, L ;

Brown, P ;

Soukharev, S ;

Yakovleva, O ;

Diringer, H ;

Saenko, EL ;

Drohan, WN .

ELECTROPHORESIS, 2003, 24 (05) :853-859

[8] Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products [J].

Foster, PR ;

Welch, AG ;

McLean, C ;

Griffin, BD ;

Hardy, JC ;

Bartley, A ;

MacDonald, S ;

Bailey, AC .

VOX SANGUINIS, 2000, 78 (02) :86-95

[9]

GROSSET A, 2005, IN PRESS PEPTIDES

[10] Prevalence of lymphoreticular prion protein accumulation in UK tissue samples [J].

Hilton, DA ;

Ghani, AC ;

Conyers, L ;

Edwards, P ;

McCardle, L ;

Ritchie, D ;

Penney, M ;

Hegazy, D ;

Ironside, JW .

JOURNAL OF PATHOLOGY, 2004, 203 (03) :733-739